Literature DB >> 23591566

Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.

María Ángeles Medrano1, Amparo Álvarez-Valdés, Josefina Perles, Julio Lloret-Fillol, Sandra Muñoz-Galván, Amancio Carnero, Carmen Navarro-Ranninger, Adoración G Quiroga.   

Abstract

The synthesis, characterization and cytotoxicity studies of two novel platinum(IV) complexes, trans-PtCl4(dma)(PPh3), 1, and trans-PtCl4(ipa)(PPh3), 2, where dma is dimethylamine and ipa is isopropylamine, have been carried out. Both complexes contain aliphatic amines trans to phosphane ligands as a good alternative to take advantage of the phosphane group lipophilicity and the stability of platinum(IV) to obtain more effective drugs. Moreover, the complexes are stable in solution and such stability allowed their antitumoral action and DNA interaction to be checked and proved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591566     DOI: 10.1039/c3cc38416k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

1.  Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes.

Authors:  Marcelo Echeverri; Amparo Alvarez-Valdés; Francisco Navas; Josefina Perles; Isabel Sánchez-Pérez; A G Quiroga
Journal:  R Soc Open Sci       Date:  2018-02-21       Impact factor: 2.963

2.  Pentafluorophenyl Platinum(II) Complexes of PTA and its N-Allyl and N-Benzyl Derivatives: Synthesis, Characterization and Biological Activity.

Authors:  Paolo Sgarbossa; Urszula Śliwińska-Hill; M Fátima C Guedes da Ilva; Barbara Bażanów; Aleksandra Pawlak; Natalia Jackulak; Dominik Poradowski; Armando J L Pombeiro; Piotr Smoleński
Journal:  Materials (Basel)       Date:  2019-11-26       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.